Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1I | Q9P0X4 | 12/20 | 0.75 |
| ▸ | KCNH2 | Q12809 | 10/20 | 0.75 |
| ▸ | CACNA1H | O95180 | 4/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.58 |
| ▸ | HTR7 | P34969 | 1/20 | 0.51 |
| ▸ | CCR2 | P41597 | 2/20 | 0.50 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4271525 | 0.93 | CACNA1I (0.72) | CACNA1IKCNH2CACNA1HCYP2D6HTR7 | |
| SCHEMBL4272201 | 0.86 | CACNA1I (0.77) | CACNA1IKCNH2CACNA1HCYP2D6HTR7 | |
| SCHEMBL4282356 | 0.86 | CACNA1I (0.71) | CACNA1IKCNH2CACNA1HCYP2D6HTR7 | |
| SCHEMBL4280632 | 0.83 | CACNA1I (0.72) | CACNA1IKCNH2CACNA1HCYP2D6HTR7 | |
| SCHEMBL8371698 | 0.83 | CACNA1I (0.58) | CACNA1IKCNH2CACNA1HCYP2D6CCR2 | |
| SCHEMBL4272268 | 0.82 | CACNA1I (0.65) | CACNA1IKCNH2CACNA1HCYP2D6HTR7 | |
| SCHEMBL19113392 | 0.82 | CACNA1I (0.73) | CACNA1IKCNH2CACNA1HCYP2D6HTR7 | |
| SCHEMBL4280558 | 0.81 | CACNA1I (0.66) | CACNA1IKCNH2CACNA1HCYP2D6HTR7 | |
| SCHEMBL4278753 | 0.81 | CACNA1I (0.72) | CACNA1IKCNH2CACNA1HCYP2D6HTR7 | |
| SCHEMBL4275125 | 0.81 | KCNH2 (0.60) | CACNA1IKCNH2CCR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3189839-A1 | N-PIPERIDINYL ACETAMIDE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | Taro Pharmaceuticals Inc. (CA) | 2017-07-12 | — | — | EP | disclosed |